Could tapping into 401k investment be a gamechanger for Houston startup funding? Photo via Getty Images

With fossil fuels facing an uncertain future, Houston is wisely pushing to further develop its innovation economy with initiatives like Houston Exponential and Rice Management Company's Ion, as well as the No. 1 ranked entrepreneurship programs at the University of Houston (undergraduate) and Rice (graduate).

Venture capital is both the critical fuel and limiting factor to expanding Houston's innovation ecosystem, but the vast majority of venture capital in this country is focused outside of Houston in places like Silicon Valley and Austin. How can we increase the local pool of venture capital focused on Houston?

A recent federal guidance provides the answer with a new option for adding dramatically to Houston's venture capital resources. On June 3rd 2020, the Department of Labor issued an information letter allowing 401k funds to invest in private equity, including venture capital. Houston has hundreds of thousands of employees contributing to 401k retirement plans, including those working at our 41 Fortune 1000 companies as well as other major employers like the Texas Medical Center hospitals. If even a small fraction of their savings could be channeled into Houston-focused venture capital funds (or funds of funds like the HX Venture Fund), it could add hundreds of millions of dollars to Houston's startup ecosystem.

How would this work? While federal guidance does not allow direct private equity investments in 401k plans, it does allow private equity to be part of the mix in target date, target risk, or balanced funds offered. Imagine the creation of a "Houston Balanced Fund" focused on a portfolio of equities and bonds from Houston companies, local government bonds, and a 15 percent allocation to Houston-focused venture capital (the maximum allowed for illiquid assets). The fund would be a bet on a prosperous long-term future for Houston — something I think many Houstonians would enthusiastically add to their retirement portfolios. Once created, it could be added to the investment options in 401k employer plans all over the city.

As an example of the power of this model: if 100,000 employees — only 3 percent of 3 million jobs in the Houston metro — invested just $10,000 of their 401k portfolios into a Houston Balanced Fund with 15 percent allocated to venture capital, it would inject an additional $150 million dollars into the local venture capital pool to spur new innovations and companies that can be the future of Houston's economy — a 20 percent increase to the $715 million of venture capital invested in Houston in 2020. This new venture capital could be leveraged even more by focusing it on early-stage Houston startups that might have trouble attracting the attention of national VC firms. As they mature to Series B rounds and beyond, they should have no trouble bringing in capital from outside the region.

This is an opportunity for Houston to do something no other city has done — to be innovative with not just new ventures and technologies, but with how they're financed. We can be proactive pioneers fueling Houston's 21st-century innovation ecosystem.

------

Tory Gattis writes the Houston Strategies blog and is a Founding Senior Fellow with the Urban Reform Institute – A Center for Opportunity Urbanism.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston healthtech startup raises $30M to scale surgical healing gel

fresh funding

Houston-based healthtech startup TYBR Health has raised a $30 million Series A round to scale its B3 GEL System, which helps protect tendons from scarring after surgery.

The round was led by Minneapolis-based Vensana Capital and Cleveland-based Mutual Capital Partners, with participation from Denver-based Neovate Capital Partners and existing investors, according to a news release from the company.

TYBR Health said it plans to use the funding to broaden the B3 GEL System's clinical applications, expand commercialization and conduct studies to evaluate its ability to protect tissue and improve healing outcomes.

"Surgeons are exceptionally good at the structural repair, but the biology that follows is what determines how it heals. That part of the equation has gone largely unaddressed ... There's a shift underway across surgical specialties, from focusing almost entirely on the mechanical repair to also weighing the biological conditions that repair needs to succeed," Tim Keane, co-founder and CEO of TYBR Health, said in the news release. "This financing lets us reach more surgeons and generate the clinical evidence to move that shift forward."

As part of the financing round, Greg Banker of Vensana Capital and Liz Todia Zambory of Mutual Capital Partners will join the TYBR board, alongside independent director Aaron Smith.

"TYBR Health is addressing a gap surgeons have lived with for a long time, with a product that fits the way they already work," Zambory, principal at Mutual Capital Partners, added in the release. "We're excited to co-lead this round and support the company's growth."

TYBR was founded in 2020 and originated from the TMCi’s Biodesign fellowship and participated in the TMC's Accelerator for HealthTech. Its B3 GEL System is a flowable extracellular matrix hydrogel designed to protect tendons, ligaments, muscles, and the surrounding soft tissue while they heal from orthopedic surgery. It received FDA 510(k) clearance last June and launched an Australian clinical trial in the fall.

The B3 GEL System has been used in hand, wrist, shoulder, foot and ankle, and sports medicine procedures since it launched, according to the company, and was first used in the clinical setting earlier this year by Dr. Tammam Hanna with Texas Tech University Health Sciences Center.

Houston space companies win NASA funding to build Mars exploration robots

mission to mars

Two Houston-area spacetech companies have landed a portion of a $17 million award from NASA to develop robots for exploring the surface of Mars, the agency announced this month.

Houston-based Inuitive Machines and Webster, Texas-based MEI Technologies, which does business as Aegis Aerospace, were among the seven companies selected to receive the funding from NASA's Science Transport and Robotic Innovation for Deployment and Exploration (STRIDE) initiative.

According to the release from NASA, the companies are tasked with creating "innovative mobility systems" that would allow future Mars missions to access more challenging terrain and difficult-to-reach regions of the planet, and to travel farther distances. NASA estimated that the work will begin this fall.

NASA solicited proposals for participants in the STRIDE initiative in January. The seven named companies are the first selected to participate in the program.

The additional five companies to receive STRIDE funding include:

"STRIDE demonstrates NASA’s commitment to strong public-private partnerships, allowing the agency to explore new approaches for Mars surface exploration while identifying key capability gaps and development needs for commercial systems that could operate and traverse realistic Martian environments," NASA shared in the announcement.

Last month, Intuitive Machines was awarded $148.3 million to deliver its Nova-C lander to the moon. The funding was part of $600 million the space agency awarded to three companies as part of its Moon Base Program and was Intuitive Machines' sixth task order under NASA's Commercial Lunar Payload Services (CLPS) program. Astrobotic was also one of the companies to land funding for the Moon Base program, as well as Austin-based Firefly Aerospace.

Around the same time, Firefly Aerospace was awarded a $13 million subcontract from NASA’s Jet Propulsion Laboratory to develop technology for NASA’s SkyFall mission to Mars. The mission aims to deploy three Mars helicopters to "perform science and demonstrate airborne subsurface mapping and resource prospecting on the planet." Read more here.